HCmed Innovations Co., Ltd. (TPE:6934)
73.00
+1.30 (1.81%)
At close: Mar 27, 2026
HCmed Innovations Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 138.55 | 65.83 | 66.61 | 123.5 | 48.49 |
Short-Term Investments | 125 | 110 | 177 | - | - |
Cash & Short-Term Investments | 263.55 | 175.83 | 243.61 | 123.5 | 48.49 |
Cash Growth | 49.89% | -27.83% | 97.26% | 154.69% | -43.59% |
Accounts Receivable | 6.38 | 1.47 | 0.29 | 0.38 | 0.1 |
Other Receivables | 0.49 | 0.22 | 0.05 | - | 0.04 |
Receivables | 6.87 | 1.7 | 0.34 | 0.38 | 0.13 |
Inventory | 13.65 | 5.56 | 5.91 | 5.39 | 11.49 |
Prepaid Expenses | 3.49 | 4.28 | 4.67 | 2.76 | 1.01 |
Other Current Assets | 0.01 | 0 | - | - | 0 |
Total Current Assets | 287.56 | 187.36 | 254.54 | 132.03 | 61.13 |
Property, Plant & Equipment | 139.77 | 28.72 | 32.23 | 14.49 | 19.58 |
Long-Term Investments | - | - | - | - | 6.59 |
Goodwill | - | - | 12.16 | 35.49 | - |
Other Intangible Assets | 1.23 | 13.9 | 20.37 | 22.61 | 0.05 |
Other Long-Term Assets | 12.63 | 16.81 | 6.79 | 2.01 | 1.81 |
Total Assets | 441.19 | 246.79 | 326.08 | 206.62 | 89.15 |
Accounts Payable | 6.93 | 1.25 | 0.72 | 1.24 | 0 |
Accrued Expenses | - | 17.71 | 14.59 | 11.04 | 9.53 |
Current Portion of Leases | 16 | 6.71 | 11.81 | 2.72 | 5.74 |
Current Unearned Revenue | - | 0.95 | 9.01 | - | - |
Other Current Liabilities | 36.85 | 6.12 | 4.45 | 5.25 | 4.35 |
Total Current Liabilities | 59.77 | 32.74 | 40.58 | 20.25 | 19.61 |
Long-Term Debt | 42.09 | - | - | - | - |
Long-Term Leases | 51.9 | 2.13 | 4.44 | 0.88 | 3.41 |
Long-Term Deferred Tax Liabilities | - | 2.6 | 4.05 | 4.52 | - |
Other Long-Term Liabilities | - | - | - | - | 238.45 |
Total Liabilities | 153.76 | 37.48 | 49.07 | 25.65 | 261.47 |
Common Stock | 327.17 | 300.34 | 300.11 | 244.11 | 175.31 |
Additional Paid-In Capital | 624.15 | 446.76 | 436.87 | 230.73 | 5.69 |
Retained Earnings | -664.12 | -538.01 | -459.79 | -293.87 | -366.97 |
Comprehensive Income & Other | 0.23 | 0.23 | -0.17 | - | 13.64 |
Shareholders' Equity | 287.43 | 209.31 | 277.01 | 180.97 | -172.32 |
Total Liabilities & Equity | 441.19 | 246.79 | 326.08 | 206.62 | 89.15 |
Total Debt | 109.99 | 8.84 | 16.25 | 3.6 | 9.15 |
Net Cash (Debt) | 153.56 | 166.99 | 227.37 | 119.9 | 39.34 |
Net Cash Growth | -8.04% | -26.55% | 89.63% | 204.77% | -53.13% |
Net Cash Per Share | 4.77 | 5.56 | 8.56 | 5.55 | 2.24 |
Filing Date Shares Outstanding | 32.85 | 30.03 | 30.01 | 24.41 | 25.63 |
Total Common Shares Outstanding | 32.85 | 30.03 | 30.01 | 24.41 | 17.53 |
Working Capital | 227.79 | 154.62 | 213.96 | 111.78 | 41.52 |
Book Value Per Share | 8.75 | 6.97 | 9.23 | 7.41 | -9.83 |
Tangible Book Value | 286.2 | 195.41 | 244.49 | 122.88 | -172.38 |
Tangible Book Value Per Share | 8.71 | 6.51 | 8.15 | 5.03 | -9.83 |
Machinery | - | 44.42 | 34.2 | 25.59 | 19.95 |
Construction In Progress | - | - | 0.55 | 0.3 | - |
Leasehold Improvements | - | 12.32 | 12.04 | 7.2 | 6.19 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.